Darunavir-O-β-D-Glucuronide
Synchemia is a leading supplier in pharmaceutical Darunavir Impurities . Darunavir (Prezista) is an antiretroviral protease inhibitor used to treat HIV-1 infection in adults and children (3 years and older) by blocking viral replication. It is always taken with other HIV medications, usually boosted by ritonavir or cobicistat, to manage HIV infection and lower the risk of infection after potential exposure.
Darunavir-O-β-D-Glucuronide CAS NO: 1159613-27-0 chemically represented as (2S,3S,4S,5R,6R)-6-(((2R,3S)-1-((4-amino-N-isobutylphenyl)sulfonamido)-3-(((((3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl)oxy)carbonyl)amino)-4-phenylbutan-2-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid . Darunavir-O-β-D-Glucuronide is supplied with comprehensive characterization data, in full compliance with applicable regulatory guidelines. Synchemia is the leading supplier and exporter of Darunavir-O-β-D-Glucuronide . All Synchemia products are strictly intended for analytical testing purposes only and not for human use.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-D3883 |
| CAS No | 159005-61-5 |
| Mol.F. | C28H35N3O5S |
| Mol.Wt. | 525.7g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3885 |
| CAS No | 664344-42-7 |
| Mol.F. | C21H32N2O5 |
| Mol.Wt. | 392.5g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-D3886 |
| CAS No | 1809154-88-8 |
| Mol.F. | C27H37N3O8S |
| Mol.Wt. | 563.7g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3887 |
| CAS No | NA |
| Mol.F. | C31H45N3O7S |
| Mol.Wt. | 603.8g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-D3888 |
| CAS No | 1399859-60-9 |
| Mol.F. | C27H37N3O7S |
| Mol.Wt. | 547.7g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3889 |
| CAS No | NA |
| Mol.F. | C27H37N3O7S |
| Mol.Wt. | 547.7g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3890 |
| CAS No | NA |
| Mol.F. | C27H36ClN3O6S |
| Mol.Wt. | 566.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3891 |
| CAS No | 1291087-81-4 |
| Mol.F. | C34H45N3O11S |
| Mol.Wt. | 703.8g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3892 |
| CAS No | 192800-79-6 |
| Mol.F. | C20H29N3O3S |
| Mol.Wt. | 391.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3893 |
| CAS No | 2514661-84-6 |
| Mol.F. | C20H29N3O3S |
| Mol.Wt. | 391.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3894 |
| CAS No | 866594-61-8 |
| Mol.F. | C7H10O4 |
| Mol.Wt. | 158.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3895 |
| CAS No | 1932330-83-0 |
| Mol.F. | C7H10O4 |
| Mol.Wt. | 158.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3896 |
| CAS No | 1932353-11-1 |
| Mol.F. | C7H10O4 |
| Mol.Wt. | 158.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3897 |
| CAS No | 866594-60-7 |
| Mol.F. | C7H10O4 |
| Mol.Wt. | 158.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3898 |
| CAS No | 156636-67-8 |
| Mol.F. | C11H19NO6 |
| Mol.Wt. | 261.3g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3899 |
| CAS No | 143224-62-8 |
| Mol.F. | C22H30N2O3 |
| Mol.Wt. | 370.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |